CVSA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne

03
Kurs $125.48
Marktkapitalisierung (MRQ) $4.27B
P/E (TTM) 17.8
EPS (TTM) $7.04
Umsatz (TTM) $1.95B
ROE (TTM) 17.5%
Verschuldungsgrad 0.5
52W-Spanne $87–$156

CVSA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen

04
Spanne
Balken

Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.

Aktiensplits 3
Ex-Datum Split Typ
22. Juni 1998 2-for-1 Vorwärts
19. Dezember 1996 2-for-1 Vorwärts
22. Juni 1995 2-for-1 Vorwärts

Über Covista Inc. Common Shares Unternehmensübersicht von Wikipedia

05 · wikidata

Covista Inc., previously Adtalem Global Education Inc. and, before that, the DeVry Education Group, is a US corporation based in Chicago, Illinois, that operates for-profit higher education institutions, including American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine, and Walden University.

Before June 2018, the corporation was known as DeVry Education Group Inc. Following a $100 million settlement with the FTC in 2016 regarding deceptive advertising, DeVry Education Group rebranded as Adtalem Global Education in 2017. Adtalem began the process to sell off DeVry University and Keller Graduate School of Management later that year to focus on healthcare professional education. Adtalem subsequently renamed itself Covista in 2026.

History

DeVry Inc. was created in 1987 with the merger of DeVry Institute of Technology (DIT) and the Keller Graduate School of Management. DIT was established in Chicago as the DeForest Training School in 1931 and was acquired by Bell & Howell in 1967. Keller was started by two DIT teachers in 1973; the company acquired DIT from Bell & Howell in 1987. DeVry Inc. went public in 1991, moved to the New York Stock Exchange in 1995, and became known as DeVry Education Group in 2013. The company was previously based in Downers Grove, Illinois.

In 2012, the company moved 150 jobs from its campus in Roscoe Village to a new office in Chicago's West Loop. The company had additional offices in Oak Brook, as of 2013. In 2015, the company opened another office in the West Loop, after the city approved a $1 million subsidy for the company in the form of tax increment financing in 2012.

In November 2013, DeVry Inc. was renamed DeVry Education Group.

Adtalem agreed to purchase Walden University for approximately $1.5 billion in September 2020. The agreement required approval by the U.S. Department of Education and the Higher Learning Commission. When the deal closed in August 2021, Adtalem became the largest provider of graduate and undergraduate degrees in nursing.

Rebranding from DeVry Education Group to Adtalem Global Education

Following a $100 million settlement with the FTC in 2016 regarding deceptive advertising, DeVry Education Group rebranded as Adtalem Global Education in 2017 and began the process to sell off DeVry University and Keller Graduate School of Management later that year. Industry analysts characterized the move as an effort to move on from DeVry's legal, financial and reputational challenges.

The company's headquarters were later relocated from Downers Grove to 500 West Monroe Street in the West Loop Gate. In 2024, Crain's Chicago Business said Adtalem had become "the largest health care educator in the nation during a post-COVID period in which the health care sector has faced severe labor shortages".

Operations

Campuses and enrollment

Adtalem's institutions operated approximately 130 campuses globally in 2018. Twelve of the 90 U.S. campuses were located in Illinois. In 2020, Adtalem's businesses operated 26 campuses in four countries and fifteen U.S. states. Approximately 90,000 students attended schools with a combined 6,100 faculty members. As of 2021, approximately 82 percent of the 140,000 students enrolled at Adtalem schools learned via distance education. In 2022, Adtalem operated 27 campuses and offered courses in 209 countries and territories.

In 2026, Covista and Advocate Health partnered to create a pipeline to place nursing graduates in the latter's hospitals. The collaboration is focused on Chamberlain University and seeks to address the nation's nursing shortage.

Leadership

Stephen Beard, who was previously Adtalem's chief operating officer, became the chief executive officer (CEO) in 2021. He was appointed the chair of the board of directors in November 2024, succeeding Michael W. Malafronte. Beard was included in Time magazine's 2025 "Time100 Health" list of influential people in the healthcare industry.

Chris Begley was the board chair in 2016. Daniel Hamburger and Lisa Wardell have previously held the CEO role. Wardell was appointed in 2016. She was the only Black woman to lead a Fortune 1000 company in 2018, according to Crain's Chicago Business. Wardell was also the board chair in 2019. In 2021, an analysis by the University of Illinois Urbana-Champaign ranked Adtalem in the top five Illinois-based public firms for both gender and racial diversity on the board.

Finances

In December 2016, DeVry Education Group agreed to a $100 million settlement of a lawsuit regarding deceptive advertising filed by the U.S Federal Trade Commission. Under the settlement, the group agreed to pay $49.4 million in cash to students and forgive $50.6 million in loans to students. In 2017, Adtalem lost approximately $4.6 million from the impacts of Hurricane Irma and Hurricane Maria. The company made a profit of $95.6 million in 2019 and lost $85.8 million in 2020, suffering from enrollment declines during the COVID-19 pandemic. In early 2024, Adtalem was targeted by a short seller and the company announced a $300 million repurchase program. In late 2024, Investor's Business Daily said Adtalem saw an average sales growth of fourteen percent over the last three years. For the 2024 fiscal year, Adtalem repurchased 5.446 million shares for approximately $261 million. In May 2025, the repurchase was completed and a new stock buyback program of up to $150 million through May 2028 was launched.

Controversies

Covista, formerly known as DeVry Education Group, has been the subject of numerous investigations and lawsuits alleging that a variety of false or deceptive practices. While the group has generally denied the allegations, several cases led to multi-million dollar settlements.

In December 2016, DeVry Education Group agreed to a $100 million settlement of a lawsuit regarding deceptive advertising filed by the U.S Federal Trade Commission. Under the settlement, the group agreed to pay $49.4 million in cash to students and forgive $50.6 million in loans to students.

Months after the FTC settlement, DeVry Education Group rebranded as Adtalem Global Education in May 2018. Adtalem rebranded as Covista in 2026.

For-profit higher education in the United States has been the subject of hearings by the United States Senate Committee on Health, Education, Labor, and Pensions. Specifically regarding DeVry, the Committee found that over half of the students enrolled at DeVry in 2008-2009 withdrew by mid-2010. As of 2015, DeVry spent more on marketing than on student instruction.

As of 2013, DeVry Inc. was under investigation by the Attorneys General of the states of Illinois and Massachusetts.

In 2014, accumulated student loan debt from DeVry University and Keller, its graduate school, had reached approximately $12.1 billion.

A lawsuit filed against DeVry alleged deceptive recruiting practices in violation of federal law.

In January 2016, The Federal Trade Commission filed a lawsuit against DeVry Education Group alleging false or misleading advertising. A class action lawsuit was also filed against DeVry Group in US District Court, Northern District of California claiming breaches of contract, good faith and fair dealing, violations of the California Unfair Trade Practices Act, the California False Advertising Act and the California Consumer Legal Remedies Act, and negligent misrepresentations. A confidential settlement was reached.

In May 2016, a shareholder class action lawsuit was filed against DeVry Group, in the US District Court, Northern District of Illinois. The plaintiffs claimed that defendants made false or misleading statements regarding DeVry University's graduate employment rate and the earnings of DeVry University graduates relative to the graduates of other universities and colleges. The case was settled in 2019 for $27.5 million.

In December 2017, a former administrator filed a civil lawsuit number with the Los Angeles Superior Court, seeking relief for a number of causes of action including Retaliation and Wrongful Termination in Violation of Public Policy for complaining about an incentive-based compensation program that rewarded campus deans for recruiting and enrolling students.

Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗

Wikidata ↗

SektorDiversified Consumer Services BrancheDiversified Consumer Services Mitarbeiter4.736 LandUS

10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends

06
Umsatz$1.95B
2021-06-30 → 2026-06-30
EPS$7.04
2021-06-30 → 2026-06-30
Freier Cashflow$393M
2021-06-30 → 2026-06-30
Nettogewinnmarge12.9%
2021-06-30 → 2026-06-30
Bewertung & Kennzahlen 07–12

Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?

Kennzahl 5-Jahres-Trend CVSA 5-Jahres-Durchschnitt Peer-Median Fazit
P/E (TTM) 17.85-Jahres-Durchschnitt ≈18.8 ≈18.8 · ·
P/S (TTM) 2.25-Jahres-Durchschnitt ≈1.8 ≈1.8 · ·
K/B (MRQ) 3.05-Jahres-Durchschnitt ≈2.2 ≈2.2 · ·
EV / EBITDA 11.85-Jahres-Durchschnitt ≈12.8 ≈12.8 · ·
Kurs / FCF (TTM) 10.95-Jahres-Durchschnitt ≈11.5 ≈11.5 · ·
Kurs / Cashflow (TTM) 9.15-Jahres-Durchschnitt ≈9.6 ≈9.6 · ·
EV / Revenue (EV / Umsatz) 2.35-Jahres-Durchschnitt ≈2.1 ≈2.1 · ·
EV / FCF 11.55-Jahres-Durchschnitt ≈13.0 ≈13.0 · ·
Kurs / Materieller Buchwert (MRQ) 6.2 · · ·
PEG Ratio (PEG-Ratio) ≈0.5 · · ·

Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.

Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median

Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR

13
Annualisierte Auszahlung≈$0.36Halbjährlich bezahlt
Ex-DatumBetragWährungRendite
Nov 30, 2016$0,18USD≈1.2%
Jun 1, 2016$0,18USD≈2.0%
Dez 2, 2015$0,18USD≈1.5%
Jun 3, 2015$0,18USD≈1.1%
Dez 3, 2014$0,18USD≈0.72%
Jun 4, 2014$0,17USD≈0.81%
Dez 4, 2013$0,17USD≈0.96%
Jun 5, 2013$0,17USD≈1.1%
Nov 28, 2012$0,17USD≈1.2%
Jun 19, 2012$0,15USD≈1.1%
Dez 6, 2011$0,15USD≈0.76%
Jun 16, 2011$0,12USD≈0.42%
Dez 8, 2010$0,12USD≈0.50%
Jun 11, 2010$0,10USD≈0.35%
Dez 9, 2009$0,10USD≈0.31%
Jun 12, 2009$0,08USD≈0.34%
Dez 10, 2008$0,08USD≈0.26%
Jun 17, 2008$0,06USD≈0.20%
Dez 12, 2007$0,06USD≈0.19%
Jun 14, 2007$0,05USD≈0.28%

Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum

14
Durchschn. Überraschung 9.8%
Nächster Bericht Okt 28, 2026
ZeitraumBerichtEPS ActualEPS est.Überraschung
30. Juni 2026 $2.09 $1.93 8.3%
31. März 2026 $1.98 $1.76 12.7%
31. Dezember 2025 $2.43 $2.23 8.9%
30. September 2025 $1.75 $1.61 8.8%
30. Juni 2025 $1.66 $1.56 6.2%
31. März 2025 $1.92 $1.69 13.9%

Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow

15
Gewinn- und Verlustrechnung 16
Kennzahl Trend 20262025202420232022202120202019
Revenue $1.95B$1.79B$1.58B$1.45B$1.38B···
Cost of Revenue $834M$771M$699M$648M$660M···
SG&A Expense $731M$672M$633M$586M$566M···
Operating Expenses $1.57B$1.45B$1.37B$1.28B$1.31B···
Operating Income $383M$342M$217M$168M$77M···
Interest Expense $45M$52M$64M$63M$129M···
Interest Income ····$4M···
Other Non-op $7M$9M$11M$7M$1M···
Pretax Income $345M$299M$164M$112M$-51M···
Income Tax $78M$66M$26M$10M$-16M···
Net Income $252M$237M$137M$93M$311M···
EPS (Basic) $7.18$6.39$3.47$2.08$6.43···
EPS (Diluted) $7.04$6.18$3.39$2.05$6.43···
Shares (Basic) 35,045,00037,085,00039,413,00044,781,00048,388,000···
Shares (Diluted) 35,715,00038,334,00040,307,00045,600,00048,388,000···
EBITDA $383M$342M$217M$168M$80M···
Bilanz 28
Kennzahl Trend 20262025202420232022202120202019
Cash & Equivalents $406M$200M$219M$272M$347M$275M$416M$67M
Short-term Investments ·······$9M
Receivables $167M$143M$124M$100M$79M$90M$69M·
Prepaid Expense $75M$69M$70M$102M$128M$167M$97M$45M
Current Assets $652M$416M$418M$480M$557M$611M$681M$390M
PP&E (Net) $303M$256M$249M$245M$290M$302M$279M$282M
PP&E (Gross) $686M$598M$575M$583M$666M$663M$618M$605M
Accum. Depreciation $383M$342M$326M$339M$376M$362M$339M$323M
Goodwill $961M$961M$961M$961M$961M$960M$310M$687M
Intangibles $754M$765M$777M$812M$874M$924M$138M$293M
Other Non-current Assets $138M$129M$103M$81M$119M$118M$88M$83M
Total Assets $3.01B$2.75B$2.74B$2.81B$3.03B$3.66B$2.27B$2.39B
Accounts Payable $125M$105M$103M$82M$57M$65M$39M$31M
Accrued Liabilities $94M$77M$97M$106M$98M$135M$97M$90M
Current Liabilities $597M$508M$488M$431M$424M$497M$341M$304M
Capital Leases $208M$186M$168M$163M$177M$156M$194M$180M
Deferred Tax $62M$32M$30M$26M$26M$27M$25M$25M
Other Non-current Liabilities $42M$40M$39M$37M$74M$58M$81M$89M
Total Liabilities $1.57B$1.32B$1.37B$1.35B$1.54B$2.37B$959M$1.09B
Long-term Debt $663M$553M$649M$695M$839M$1.61B$287M$415M
Total Debt $663M$553M$649M$695M$839M···
Common Stock $848.0K$839.0K$832.0K$822.0K$818.0K$817.0K$810.0K$806.0K
Retained Earnings $3.03B$2.78B$2.54B$2.40B$2.31B$1.96B$1.97B$2.03B
Treasury Stock $2.29B$2.01B$1.78B$1.51B$1.34B$1.22B$1.16B$1.08B
AOCI $-2M$-2M$-2M$-2M$-2M$-634.0K$-8M$-159M
Stockholders' Equity $1.45B$1.43B$1.37B$1.46B$1.49B$1.28B$1.31B$1.29B
Liabilities + Equity $3.01B$2.75B$2.74B$2.81B$3.03B$3.66B$2.27B$2.39B
Shares Outstanding 34,033,00035,952,00037,681,00082,232,00081,796,00081,705,00081,021,00052,953,000
Cashflow 16
Kennzahl Trend 20262025202420232022202120202019
Stock-based Comp $41M$42M$26M$14M$23M···
Deferred Tax $68M$18M$11M$-5M$-14M···
Amort. of Intangibles $11M$11M$36M$61M$97M···
Restructuring $6M$3M$2M$19M$26M···
Operating Cash Flow $470M$338M$296M$192M$11M···
CapEx $78M$50M$49M$26M$31M···
Investing Cash Flow $-84M$-42M$-48M$24M$-552M···
Debt Issued $1.01B$10M$2M$0$850M···
Net Debt Issued $112M$-100M$-50M$-151M$-230M···
Stock Repurchased $240M$213M$262M$123M$120M···
Net Stock Activity $-240M$-213M$-262M$-123M$-120M···
Financing Cash Flow $-180M$-316M$-302M$-289M$-424M···
Net Change in Cash $207M$-20M$-54M$-73M$-966M···
Taxes Paid $14M$33M$31M$12M$94M···
Free Cash Flow $393M$288M$247M$166M$-21M···
Levered FCF $358M$247M$193M$109M$-106M···
Rentabilität 7
Kennzahl Trend 20262025202420232022202120202019
Operating Margin 19.6%19.1%13.7%11.6%5.8%···
Net Margin 12.9%13.3%8.6%6.4%22.9%···
Pretax Margin 17.7%16.7%10.3%7.7%-3.2%···
EBITDA Margin 19.6%19.1%13.7%11.6%5.8%···
ROA 8.7%8.6%4.9%3.3%9.7%···
ROE 17.8%16.5%10.2%6.3%21.3%···
ROIC 14.1%13.4%9.0%7.1%2.3%···
Liquidität & Solvenz 5
Kennzahl Trend 20262025202420232022202120202019
Current Ratio 1.10.80.91.11.3···
Quick Ratio 1.00.70.70.91.0···
Debt / Equity 0.50.40.50.50.6···
LT Debt / Equity 0.50.40.50.50.6···
Interest Coverage 8.46.53.42.70.6···
Effizienz 2
Kennzahl Trend 20262025202420232022202120202019
Asset Turnover 0.70.70.60.50.4···
Receivables Turnover 12.613.414.116.216.1···
Pro Aktie 5
Kennzahl Trend 20262025202420232022202120202019
Book Value / Share $42.49$39.88$36.33$34.44$33.31···
Revenue / Share $54.71$46.65$39.31$31.82$28.67···
Cash Flow / Share $13.17$8.81$7.34$4.45$0.22···
Cash / Share $11.94$5.55$5.82$6.47$7.68···
EPS (TTM) $7.04$6.18$3.39$2.05$6.43···
Wachstumsraten 9
Kennzahl Trend 20262025202420232022202120202019
Revenue YoY 9.3%12.8%9.2%5.0%53.7%···
Revenue CAGR 3Y 10.4%9.0%20.8%18.8%····
Revenue CAGR 5Y 16.8%15.6%······
EPS YoY 13.9%82.3%65.4%-68.1%372.8%···
EPS CAGR 3Y 50.9%-1.3%35.6%·····
EPS CAGR 5Y 38.9%·······
Net Income YoY 6.1%73.3%46.5%-70.0%344.1%···
Net Income CAGR 3Y 39.2%-8.6%25.0%·····
Net Income CAGR 5Y 29.1%·······
Bewertung (TTM) 13
Kennzahl Trend 20262025202420232022202120202019
Revenue TTM $1.95B$1.79B$1.58B$1.45B$1.38B···
Net Income TTM $252M$237M$137M$93M$311M···
Market Cap $4.24B$4.57B$2.57B$1.45B$1.63B···
Enterprise Value $4.50B$4.93B$3.00B$1.87B$2.12B···
P/E 17.720.620.116.85.6···
P/S 2.22.61.61.01.2···
P/B 2.93.21.91.01.1···
P / Cash Flow 9.013.58.77.2155.9···
P / FCF 10.815.910.48.8-78.8···
EV / EBITDA 11.714.413.811.126.3···
EV / FCF 11.517.112.211.3-102.6···
EV / Revenue 2.32.81.91.31.5···
Earnings Yield 5.7%4.9%5.0%6.0%17.9%···

Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt

Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre

16
Kennzahl 2026-06-302025-06-302024-06-302023-06-302022-12-31
Umsatz $1.95B $1.79B $1.58B $1.45B ·
Betriebsgewinnmarge % 19.6% 19.1% 13.7% 11.6% ·
Nettoergebnis $252M $237M $137M $93M ·
Verwässerte EPS $7.04 $6.18 $3.39 $2.05 ·

Institutionelle Eigentümer (13F) 399 Einreicher · $4.5B gesamt · Stand 30. September 2026

17

Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.

Inhaber 399
Gehaltener Wert $4.5B
Neue Positionen 53
Geschlossene Positionen 30
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
Neue Positionen Geschlossene Positionen Erhöht Abgenommen Nettoveränderung der Aktien
53 (0 vs. Vorquartal) 30 (-22 vs. Vorquartal) 142 (+2 vs. Vorquartal) 135 (+4 vs. Vorquartal) -171K

Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.

Institution Wert Aktien % der verfolgten 13F Typ
BlackRock, Inc. $683.177.439 5.480.326 15,10% Aktien
VANGUARD GROUP INC $449.985.960 4.348.951 9,94% Aktien
FMR LLC $401.181.165 3.218.203 8,87% Aktien
VANGUARD PORTFOLIO MANAGEMENT LLC $297.558.184 2.386.958 6,58% Aktien
DIMENSIONAL FUND ADVISORS LP $222.235.571 1.782.750 4,91% Aktien
ARIEL INVESTMENTS, LLC $220.878.073 1.771.844 4,88% Aktien
VANGUARD CAPITAL MANAGEMENT LLC $183.742.358 1.473.948 4,06% Aktien
STATE STREET CORP $173.212.203 1.389.477 3,83% Aktien
Capital World Investors $132.593.736 1.063.643 2,93% Aktien
GEODE CAPITAL MANAGEMENT, LLC $111.498.699 894.257 2,46% Aktien
WELLINGTON MANAGEMENT GROUP LLP $99.984.176 802.055 2,21% Aktien
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $78.581.301 630.365 1,74% Aktien
Boston Partners $71.229.785 567.172 1,57% Aktien
FRANKLIN RESOURCES INC $70.714.009 567.255 1,56% Aktien
Alyeska Investment Group, L.P. $68.807.458 551.961 1,52% Aktien
Fisher Asset Management, LLC $63.050.035 505.776 1,39% Aktien
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $60.245.186 483.276 1,33% Aktien
MORGAN STANLEY $58.961.768 472.980 1,30% Aktien
NORTHERN TRUST CORP $54.225.605 434.988 1,20% Aktien
NEUMEIER POMA INVESTMENT COUNSEL LLC $44.010.839 353.047 0,97% Aktien
FRONTIER CAPITAL MANAGEMENT CO LLC $37.728.848 302.654 0,83% Aktien
AQR CAPITAL MANAGEMENT LLC $33.376.692 271.952 0,74% Aktien
TWO SIGMA INVESTMENTS, LP $32.342.164 259.443 0,71% Aktien
VANGUARD FIDUCIARY TRUST CO $30.437.360 244.163 0,67% Aktien
Bank of New York Mellon Corp $28.712.585 230.327 0,63% Aktien
PRINCIPAL FINANCIAL GROUP INC $26.394.013 211.728 0,58% Aktien
Allianz Asset Management GmbH $24.804.472 198.977 0,55% Aktien
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $24.151.629 193.740 0,53% Aktien
Nuveen, LLC $23.937.712 192.024 0,53% Aktien
SG Capital Management LLC $22.238.845 178.396 0,49% Aktien
BANK OF AMERICA CORP /DE/ $21.978.929 176.311 0,49% Aktien
GOLDMAN SACHS GROUP INC $20.337.780 163.146 0,45% Aktien
TWO SIGMA ADVISERS, LP $19.876.587 192.100 0,44% Aktien
ALGERT GLOBAL LLC $19.323.048 155.006 0,43% Aktien
Invesco Ltd. $18.361.795 147.295 0,41% Aktien
Public Sector Pension Investment Board $17.393.810 139.530 0,38% Aktien
Corient Private Wealth LP $17.190.989 137.903 0,38% Aktien
PRUDENTIAL FINANCIAL INC $15.911.852 127.642 0,35% Aktien
WESTPORT ASSET MANAGEMENT INC $15.677.117 125.759 0,35% Aktien
MACKENZIE FINANCIAL CORP $13.510.152 108.376 0,30% Aktien
WELLS FARGO & COMPANY/MN $12.758.571 102.347 0,28% Aktien
Qube Research & Technologies Ltd $12.647.380 101.455 0,28% Aktien
RHUMBLINE ADVISERS $10.647.181 85.410 0,24% Aktien
Legal & General Group Plc $10.482.784 84.091 0,23% Aktien
LGT CAPITAL PARTNERS LTD. $10.035.130 80.500 0,22% Aktien
MILLENNIUM MANAGEMENT LLC $9.671.247 77.581 0,21% Aktien
Foresight Group Ltd Liability Partnership $9.636.366 77.264 0,21% Aktien
AMERICAN CENTURY COMPANIES INC $9.436.388 75.697 0,21% Aktien
ALLIANCEBERNSTEIN L.P. $8.879.782 77.048 0,20% Aktien
LAZARD ASSET MANAGEMENT LLC $8.696.157 69.759 0,19% Aktien

Alle 399 institutionellen Eigentümer anzeigen →

Aktivisten & 5%+-Eigentümer 1 Beteiligung

18

Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.

Anmelder Eingereicht Beteiligung Status Zweck Einreichung
International Value Advisers, LLC, Charles de Vaulx ×18 Einreichungen 7. August 2020 · Erste Einreichung · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Unternehmensinsider 113 Insider · 51 Führungskräfte · 26 Direktoren

19
Insider Rolle Letzte Aktivität Gehaltene Aktien Käufe 12m Verkäufe 12m Netto 12m
Stephen W. Beard, Chairman & CEO 23. August 2026 F 477.464 0 5 $-3.938.087
Daniel Hamburger President and CEO 31. August 2015 S 142.136 0 0 $0
Robert J. Phelan Chief Financial Officer 23. August 2026 F 56.571 0 4 $-2.277.058
Michael O Randolfi SVP, Chief Financial Officer 28. August 2020 F 84.391 0 0 $0
Timothy J Wiggins SVP & Chief Financial Officer 25. Februar 2016 S 44.939 0 0 $0
Richard Gunst Chief Financial Officer 1. Februar 2012 M 9.356 0 0 $0
Amelia Manning President, Chamberlain Univ. 15. Juli 2026 A 4.317 0 0 $0
Karen Sue Cox President, Chamberlain Univ. 8. Mai 2026 S 31.596 0 1 $-249.000
Scott Liles President, Medical and Vet 15. April 2026 F 13.103 0 0 $0
Evan Trent President, Adtalem Elevate 13. November 2025 F 24.134 0 0 $0
Thiago Aguiar Sayao Group President, Business &Law 28. Februar 2020 S 1.830 0 0 $0
Carlos Filgueiras Group President, Tech/Business 13. Februar 2019 S 11.775 0 0 $0
Donna M Loraine President, Carrington Colleges 6. November 2018 M 6.701 0 0 $0
Susan Groenwald President, Chamberlain 9. Februar 2018 M 34.402 0 0 $0
John P Roselli President, Becker Professional 1. September 2017 S 13.730 0 0 $0
Eric P. Dirst President, ATGE Shared Ops 31. August 2017 S 14.800 0 0 $0
Robert A Paul President, DeVry University 25. August 2017 M 28.426 0 0 $0
Steven Riehs President, Med, Prof & Online 2. September 2016 M 28.062 0 0 $0
Jeffrey Richard Akens President, Carrington College 29. August 2015 F 6.752 0 0 $0
Christopher Caywood President, Online Services 1. März 2013 F 7.378 0 0 $0
Andrew A Jeon President, DeVry Medical Int'l 2. November 2012 F 5.655 0 0 $0
William B. Hughson President, Medical & 29. August 2012 A 2.143 0 0 $0
George Montgomery President, U.S. Education 27. August 2010 A · 0 0 $0
Manjunath Gangadharan VP, Chief Accounting Officer 27. August 2026 S 5.083 0 1 $-247.198
Michael Betz Pres. Walden University & CDO 23. August 2026 F 39.172 0 0 $0
Douglas G. Beck SVP, GC, Corp. Sec & ISS 23. August 2026 F 33.394 0 4 $-2.524.973
Maurice Herrera SVP - Chief Marketing Officer 13. November 2025 F 20.584 0 0 $0
Megan Noel Chief Corp. Affairs Officer 12. November 2025 A 2.226 0 0 $0
Sara Hill CHRO 12. November 2025 A 10.276 0 0 $0
Blake Simpson SVP, Chief Comms & CA Officer 5. Dezember 2024 F 8.795 0 0 $0
Steven Tom SVP Chief Customer Officer 13. November 2024 A 13.255 0 0 $0
Cheryl James SVP, CHRO 28. Februar 2024 F 17.485 0 0 $0
John W Danaher MD Pres. - Adtalem Med & Vet 25. August 2023 F 38.718 0 0 $0
James Raymond Bartholomew SVP - Chamberlain University 26. August 2022 F 6.418 0 0 $0
Holland Katherine Alice Boden Group Pres, Adtalem Health 30. August 2021 F 32.148 0 0 $0
Fernando Lau SVP, Chief Marketing Officer 28. August 2021 F 19.253 0 0 $0
Christopher C Nash SVP, Chief Information Officer 28. August 2021 F 25.741 0 0 $0
Donna Jennings SVP, Human Resources 28. August 2021 F 30.898 0 0 $0
Chaka M Patterson SVP and General Counsel 28. August 2020 F 5.202 0 0 $0
Mehul R Patel Group Pres, Financial Services 7. November 2019 F 11.258 0 0 $0
Kathleen Carroll Vice President, Controller 28. August 2019 A 5.497 0 0 $0
Lisa M Sodeika SVP, Corporate Affairs 28. August 2019 A 24.151 0 0 $0
Patrick J Unzicker Principal Financial Officer 27. August 2019 F 36.360 0 0 $0
Catherine C. Anderson SVP, Strategy & Innovation 26. August 2019 F 6.025 0 0 $0
Gena L Ashe SVP, CLO and Secretary 23. August 2017 A 4.420 0 0 $0
Gregory S Davis SVP and General Counsel 1. September 2016 S 22.433 0 0 $0
Adriano Allegrini VP, Strategy and Bus. Develop. 29. August 2015 F 7.004 0 0 $0
Sharon Thomas Parrott SVP, Gov. & Regulatory Affairs 5. November 2014 A 5.610 0 0 $0
David J Pauldine Executive Vice President & 25. April 2014 M 30.242 0 0 $0
Thomas C Shepherd Executive Vice President and 27. Mai 2011 M 0 0 0 $0
Thomas J Vucinic Sr. Vice President & President 27. August 2010 A 258 0 0 $0
Michael W Malafronte Direktor 31. August 2026 G 110.705 5 0 $3.844.716
William V Krehbiel Direktor 13. November 2025 F 16.303 0 0 $0
Betty M. Vandenbosch Direktor 13. November 2025 F 2.584 0 0 $0
Kenneth J Phelan Direktor 13. November 2025 F 19.836 1 0 $49.931
Georgette D. Kiser Direktor 13. November 2025 F 17.481 0 0 $0
Lisa W Wardell Direktor 13. November 2025 F 44.251 0 0 $0
Donna J Hrinak Direktor 13. November 2025 F 8.218 0 0 $0
William W Burke Direktor 13. November 2025 F 10.423 0 0 $0
Sharon O'Keefe Direktor 12. November 2025 A 16.597 0 0 $0
Mayur Gupta Direktor 8. November 2024 F 6.667 0 0 $0
Charles Deshazer Direktor 9. November 2023 F 5.132 0 0 $0
James D White Direktor 11. Februar 2021 P 13.152 0 0 $0
Steven Altschuler Direktor 6. November 2019 A 6.170 0 0 $0
Ann Hart Direktor 8. November 2018 F 7.117 0 0 $0
Fernando Ruiz Direktor 10. November 2016 A 16.956 0 0 $0
David S Brown Direktor 5. November 2016 F 5.182 0 0 $0
Alan G Merten Direktor 5. November 2016 F 9.302 0 0 $0
Connie R Curran Direktor 7. November 2014 F 13.295 0 0 $0
Darren Richard Huston Direktor 7. Juli 2014 F 10.436 0 0 $0
William T Keevan Direktor 10. November 2013 F 15.041 0 0 $0
Julie A Mcgee Direktor 10. November 2013 F 24.542 0 0 $0
Harold T Shapiro Direktor 3. November 2013 F 8.879 0 0 $0
Gary C Butler Direktor 3. November 2012 F 4.275 0 0 $0
MICROSOFT CORP Direktor 10. November 2009 A 1.290 0 0 $0
KREHBIEL FREDERICK A Direktor 29. Oktober 2008 S 1.700 0 0 $0
Dennis J Keller 10%-Eigentümer 25. August 2010 G 5.760.787 0 0 $0
Lyle Logan · 8. November 2022 S 27.048 0 0 $0
Ronald L Taylor · 8. November 2018 F 424.605 0 0 $0
Christopher B Begley · 10. November 2016 A 15.057 0 0 $0
Charles A Bowsher · 29. Januar 2008 M 2 0 0 $0
Harvey Leffring · 7. November 2007 A · 0 0 $0
Patrick L Mayers · 30. Oktober 2007 S 2.500 0 0 $0
Paul E. Eppen · 29. Oktober 2007 M 7.477 0 0 $0
Robert C Mccormack · 29. Oktober 2007 M 1.784 0 0 $0
Norman M Levine · 17. August 2007 S 10.500 0 0 $0
Kenneth Rutkowski · 9. Februar 2007 M 7.514 0 0 $0
John O Skubiak · 8. Februar 2007 G 29.575 0 0 $0
Rose Marie Dishman · 8. Februar 2007 S 0 0 0 $0
Jack Calabro · 31. Januar 2007 S 0 0 0 $0
John M Holbrook · 3. Oktober 2006 A · 0 0 $0
Robert C Le Valley · 3. Oktober 2006 A 0 0 0 $0
Gerald A Murphy · 3. Oktober 2006 A 3.125 0 0 $0
James W Kho · 3. Oktober 2006 A · 0 0 $0
Galen Graham · 3. Oktober 2006 A 489 0 0 $0
James A Dugan · 3. Oktober 2006 A 0 0 0 $0
Jerry R Dill · 3. Oktober 2006 A 400 0 0 $0
Thomas Babel · 3. Oktober 2006 A · 0 0 $0
Timothy H Ricordati · 13. September 2006 M 12.400 0 0 $0
Timothy J Joyce · 22. Dezember 2005 S 2.534 0 0 $0
Gerald J Wawrzynek · 8. Dezember 2005 M 5.500 0 0 $0
George W Fisher · 16. November 2005 M 1.640 0 0 $0
Marilynn J Cason · 26. August 2005 G 8.961 0 0 $0
Fredric M Weber · 25. Mai 2005 M 1.000 0 0 $0
Hugo J Melvoin · 29. April 2005 G 7.412 0 0 $0
David M Webster · 27. April 2005 A · 0 0 $0
Edward J Steffes · 27. April 2005 S 0 0 0 $0
Thurston E Manning · 15. Februar 2005 S 27.450 0 0 $0
Michael J Alexander · 10. August 2004 A · 0 0 $0
Bruno R Lacaria · 10. August 2004 A · 0 0 $0
Cecil Horst · 10. August 2004 A 2.025 0 0 $0
Ronald Baron · 20. August 2003 S 58.898 0 0 $0
Timothy E Foster · 15. August 2003 A · 0 0 $0

Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten

ETF-Besitz Gehalten von 61 ETFs

20

Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.

Fonds Gewicht Anteile Stand Quelle
PSCD · Invesco Exchange-Traded Fund Trust … 1,87% 3.441 SH 1. Oktober 2026 Täglich
PSL · Invesco Exchange-Traded Fund Trust 1,66% 10.434 SH 1. Oktober 2026 Täglich
CAFG · Pacer Funds Trust 1,07% 2.587 NS 31. Juli 2026 N-PORT
JSML · Janus Detroit Street Trust 1,03% 29.835 NS 31. Juli 2026 N-PORT
MYLD · Cambria ETF Trust 0,95% 2.595 NS 31. Juli 2026 N-PORT
XSHQ · Invesco Exchange-Traded Fund Trust … 0,90% 21.068 SH 1. Oktober 2026 Täglich
RZG · Invesco Exchange-Traded Fund Trust 0,86% 8.402 SH 1. Oktober 2026 Täglich
JSMD · Janus Detroit Street Trust 0,74% 62.173 NS 31. Juli 2026 N-PORT
VIOG · VANGUARD ADMIRAL FUNDS 0,46% 40.509 SH 19. August 2026 Täglich
SMDX · Tidal Trust III 0,34% 3.536 NS 31. Juli 2026 N-PORT
NUSC · Nushares ETF Trust 0,32% 33.449 NS 31. Juli 2026 N-PORT
QVMS · Invesco Exchange-Traded Fund Trust … 0,28% 5.402 SH 1. Oktober 2026 Täglich
IWO · iShares Trust 0,28% 323.692 SH 11. September 2026 Täglich
FYC · First Trust Exchange-Traded AlphaDE… 0,27% 28.163 NS 31. Juli 2026 N-PORT
VTWG · VANGUARD SCOTTSDALE FUNDS 0,25% 36.861 SH 19. August 2026 Täglich
VIOO · VANGUARD ADMIRAL FUNDS 0,23% 119.030 SH 19. August 2026 Täglich
PRFZ · Invesco Exchange-Traded Fund Trust 0,23% 50.636 SH 1. Oktober 2026 Täglich
JPSE · J.P. Morgan Exchange-Traded Fund Tr… 0,22% 10.374 NS 31. Juli 2026 N-PORT
DFAT · Dimensional ETF Trust 0,20% 230.892 NS 31. Juli 2026 N-PORT
OMFS · Invesco Exchange-Traded Self-Indexe… 0,20% 4.269 SH 1. Oktober 2026 Täglich
BKSE · BNY Mellon ETF Trust 0,19% 1.310 NS 31. Juli 2026 N-PORT
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0,16% 9.079 NS 31. Juli 2026 N-PORT
FSMD · FIDELITY COVINGTON TRUST 0,15% 30.619 NS 31. Juli 2026 N-PORT
IWM · iShares Trust 0,14% 882.577 SH 11. September 2026 Täglich
RSSL · Global X Funds 0,14% 16.493 NS 31. Juli 2026 N-PORT
ISCG · iShares Trust 0,14% 10.597 SH 11. September 2026 Täglich
VTWO · VANGUARD SCOTTSDALE FUNDS 0,13% 198.216 SH 19. August 2026 Täglich
FDIS · FIDELITY COVINGTON TRUST 0,13% 17.290 NS 31. Juli 2026 N-PORT
RWJ · Invesco Exchange-Traded Fund Trust … 0,12% 19.657 SH 1. Oktober 2026 Täglich
VFQY · VANGUARD WELLINGTON FUND 0,12% 4.599 SH 19. August 2026 Täglich
VCR · VANGUARD WORLD FUND 0,12% 67.714 SH 19. August 2026 Täglich
PKW · Invesco Exchange-Traded Fund Trust 0,11% 14.767 SH 1. Oktober 2026 Täglich
VFMF · VANGUARD WELLINGTON FUND 0,10% 5.421 SH 19. August 2026 Täglich
DFAS · Dimensional ETF Trust 0,09% 111.792 NS 31. Juli 2026 N-PORT
VBR · VANGUARD INDEX FUNDS 0,09% 470.701 SH 19. August 2026 Täglich
ESML · iShares Trust 0,07% 16.800 SH 11. September 2026 Täglich
FYX · First Trust Exchange-Traded AlphaDE… 0,06% 6.997 NS 31. Juli 2026 N-PORT
FAD · First Trust Exchange-Traded AlphaDE… 0,06% 2.549 NS 31. Juli 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,05% 390.261 SH 19. August 2026 Täglich
VB · VANGUARD INDEX FUNDS 0,05% 741.686 SH 19. August 2026 Täglich
DFSV · Dimensional ETF Trust 0,04% 27.984 NS 31. Juli 2026 N-PORT
DXUV · Dimensional ETF Trust 0,04% 1.783 NS 31. Juli 2026 N-PORT
WSML · iShares Trust 0,04% 2.071 SH 11. September 2026 Täglich
DFUV · Dimensional ETF Trust 0,02% 30.155 NS 31. Juli 2026 N-PORT
DFAC · Dimensional ETF Trust 0,02% 91.061 NS 31. Juli 2026 N-PORT
DFSU · Dimensional ETF Trust 0,02% 3.775 NS 31. Juli 2026 N-PORT
DCOR · Dimensional ETF Trust 0,01% 3.622 NS 31. Juli 2026 N-PORT
TILT · FlexShares Trust 0,01% 2.106 NS 31. Juli 2026 N-PORT
VTI · VANGUARD INDEX FUNDS 0,01% 1.024.746 SH 19. August 2026 Täglich
VTHR · VANGUARD SCOTTSDALE FUNDS 0,01% 2.840 SH 19. August 2026 Täglich
ESGV · VANGUARD WORLD FUND 0,01% 7.618 SH 19. August 2026 Täglich
DFAU · Dimensional ETF Trust 0,01% 7.798 NS 31. Juli 2026 N-PORT
DFUS · Dimensional ETF Trust 0,01% 10.330 NS 31. Juli 2026 N-PORT
ITOT · iShares Trust 0,01% 44.952 SH 11. September 2026 Täglich
IWV · iShares Trust 0,01% 9.317 SH 11. September 2026 Täglich
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0,00% 25.773 SH 19. August 2026 Täglich
IJR · iShares Trust · 2.076.826 SH 10. September 2026 Täglich
IJT · iShares Trust · 321.953 SH 9. September 2026 Täglich
XJR · iShares Trust · 4.693 SH 31. August 2026 Täglich
ISCB · iShares Trust · 1.501 SH 11. September 2026 Täglich
SMLF · iShares Trust · 41.983 SH 11. September 2026 Täglich

CVSA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial

21
Bewertung · 10 Analysten KAUF
Median-Ziel $161.50 +28,7%
4 40,0% Starker Kauf
5 50,0% Kauf
1 10,0% Halten
0 0,0% Verkauf
0 0,0% Starker Verkauf

12-Monats-Kursziel

4 Analysten · 2026-09-29

Mittelwert-Ziel $159.50 +27,1%

← Unter allen Zielen Aktueller Preis $125.48
Tief$140.00 Mittelwert$159.50 Hoch$175.00

Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen

22

FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.

Ticker Marktkapitalisierung P/E Umsatz Vj. Nettomarge ROE Bruttogewinnmarge
CVSA $4.24B 17.7 9.3% 12.9% 17.8% ·
DUOL $8.18B 20.5 38.7% 39.9% 35.6% 72.2%
LAUR $4.81B 17.8 8.6% 16.6% 26.2% ·
GHC · 16.5 2.5% 5.9% 6.5% ·
LOPE $4.56B 21.6 7.1% 19.5% 28.3% ·
LRN $3.58B 12.1 4.7% 13.4% 21.3% 37.8%
BFAM $5.64B 30.2 9.2% 6.6% 14.1% 23.8%
MH $2.62B 72.1 0.07% 1.7% 4.6% 80.9%
PRDO $1.83B 12.1 24.2% 18.9% 16.3% ·
STRA $1.84B 14.8 4.0% 10.0% 7.6% ·
COUR · -23.7 9.0% · · ·

Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen

23

Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten

26

Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.

Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.

Quelle: SEC 10-K eingereicht Aug 6, 2026